Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
After 'complete standstill,' biotech market reaches new normal
The first half of 2025 was brutal for biotech, but investors are still keen on therapeutics in several areas, such as cardiorenal and neuropsych.
Gabrielle Masson
Aug 20, 2025 11:04am
Gene therapy biotech Kriya catches $313M
Aug 18, 2025 4:52pm
Fierce Biotech Fundraising Tracker: Kriya, Strand & more
Aug 18, 2025 3:00pm
Hatteras handles $200M across 2 funds for life science startups
Aug 13, 2025 10:28am
Big Pharmas back Strand's $153M series B to advance mRNA drugs
Aug 7, 2025 9:20am
Minghui raises $131M to fund JAK inhibitor launch, ADC trials
Aug 7, 2025 8:15am
